New registry tracks side effects of targeted radiation for spread cancer

NCT ID NCT04085029

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a registry that collects information from 300 adults with metastatic cancer who receive or have received a precise, high-dose form of radiation called ablative radiotherapy. The goal is to track short-term side effects and better understand the safety of this treatment. No new drug or therapy is being tested; instead, researchers are gathering real-world data to guide future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ablative radiotherapy
What this could lead to
If successful, this registry could help doctors better understand the safety of ablative radiotherapy for metastatic cancer, potentially improving treatment guidelines.
What could go wrong
This is an observational registry, not a treatment trial. It does not test whether the therapy works, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duke Cancer Institute Cary

    RECRUITING

    Cary, North Carolina, 27518, United States

  • Duke Raleigh Hospital

    RECRUITING

    Raleigh, North Carolina, 27609, United States

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Duke Women's Cancer Care Raleigh

    RECRUITING

    Raleigh, North Carolina, 27607, United States

  • Durham Veterans Administration Health Care System (DVAHCS)

    RECRUITING

    Durham, North Carolina, 27705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.